Literature DB >> 35015350

COVID-19 vaccination uptake in people with severe mental illness: a UK-based cohort study.

Lamiece Hassan1, Chelsea Sawyer1, Niels Peek2,3,4, Karina Lovell5, Andre F Carvalho6, Marco Solmi7,8,9, George Tilston2,4, Matthew Sperrin2, Joseph Firth1,10.   

Abstract

Entities:  

Year:  2022        PMID： 35015350      PMCID： PMC8751570          DOI： 10.1002/wps.20945

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  6 in total

1.  Physical health care in persons with severe mental illness: a public health and ethical priority.

Authors:  Mario Maj
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

2.  Maximizing the Uptake of a COVID-19 Vaccine in People With Severe Mental Illness: A Public Health Priority.

Authors:  Nicola Warren; Steve Kisely; Dan Siskind
Journal:  JAMA Psychiatry       Date:  2021-06-01       Impact factor: 21.596

3.  Prioritizing COVID-19 vaccination for people with severe mental illness.

Authors:  Marc De Hert; Victor Mazereel; Johan Detraux; Kristof Van Assche
Journal:  World Psychiatry       Date:  2020-11-01       Impact factor: 49.548

4.  Patients with schizophrenia are under-vaccinated for COVID-19: a report from Israel.

Authors:  Dana Tzur Bitan
Journal:  World Psychiatry       Date:  2021-06       Impact factor: 49.548

5.  Severe mental illness and European COVID-19 vaccination strategies.

Authors:  Livia J De Picker; Marisa Casanova Dias; Michael E Benros; Benedetta Vai; Igor Branchi; Francesco Benedetti; Alessandra Borsini; Juan Carlos Leza; Hilkka Kärkkäinen; Miia Männikkö; Carmine M Pariante; Ekin Sönmez Güngör; Anna Szczegielniak; Ryad Tamouza; Afra van der Markt; Paolo Fusar-Poli; Julian Beezhold; Marion Leboyer
Journal:  Lancet Psychiatry       Date:  2021-02-17       Impact factor: 27.083

6.  Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States.

Authors:  QuanQiu Wang; Rong Xu; Nora D Volkow
Journal:  World Psychiatry       Date:  2020-10-07       Impact factor: 79.683
  6 in total
  5 in total

1.  COVID-19 Booster Vaccination Among Individuals With Schizophrenia in Israel.

Authors:  Dana Tzur Bitan; Khalaf Kridin; Noga Givon-Lavi; Israel Krieger; Ehud Kaliner; Arnon Dov Cohen; Orly Weinstein
Journal:  JAMA Psychiatry       Date:  2022-05-01       Impact factor: 25.911

2.  Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia.

Authors:  Stéphane Raffard; Sophie Bayard; Margot Eisenblaetter; Philippe Tattard; Jérôme Attal; Yasmine Laraki; Delphine Capdevielle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-04-30       Impact factor: 5.760

3.  COVID-19 vaccination rates in hospitalized mentally ill patients compared to the general population in Germany: Results from the COVID Ψ Vac study.

Authors:  Hauke F Wiegand; Birgit Maicher; Mike Rueb; Paula Wessels; Bianca Besteher; Sabine Hellwig; Andrea Pfennig; Henrik Rohner; Stefan Unterecker; Lars P Hölzel; Alexandra Philipsen; Katharina Domschke; Peter Falkai; Klaus Lieb; Kristina Adorjan
Journal:  Eur Psychiatry       Date:  2022-06-28       Impact factor: 7.156

4.  Attitudes towards Vaccines, Intent to Vaccinate and the Relationship with COVID-19 Vaccination Rates in Individuals with Schizophrenia.

Authors:  Stéphane Raffard; Sophie Bayard; Margot Eisenblaetter; Jérôme Attal; Christelle Andrieu; Isabelle Chereau; Guillaume Fond; Sylvain Leignier; Jasmina Mallet; Philippe Tattard; Mathieu Urbach; David Misdrahi; Yasmine Laraki; Delphine Capdevielle
Journal:  Vaccines (Basel)       Date:  2022-07-31

5.  Impact of the COVID-19 pandemic on non-COVID-19 hospital mortality in patients with schizophrenia: a nationwide population-based cohort study.

Authors:  Laurent Boyer; Guillaume Fond; Vanessa Pauly; Veronica Orléans; Pascal Auquier; Marco Solmi; Christoph U Correll; Dong Keon Yon; Pierre-Michel Llorca; Karine Baumstarck-Barrau; Antoine Duclos
Journal:  Mol Psychiatry       Date:  2022-10-07       Impact factor: 13.437
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.